
Abcam Investor Relations Material
Latest events

H2 2022
Abcam
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Abcam plc
Access all reports
Abcam plc is a global provider of life science research tools, specializing in the development and marketing of reagents and tools essential for research in the life sciences sector. The company's extensive product range includes primary and secondary antibodies, immunoassay kits, cellular and biochemical assays, proteins and peptides, as well as products for cell and tissue imaging. Abcam serves a broad array of customers including researchers in academia, clinical labs, and pharmaceutical, biotech, and diagnostic companies. Abcam is headquartered in Cambridge, Cambridgeshire, UK, and its shares are listed on the Nasdaq.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ABCM
Country
🇺🇸 United States